AI entity
Every one of those 1 sits in a single category, ai-research. Of the tracked stories, 1 of 1 also mention AI/ML, the most common co-covered peer. Their average consequence score of 6 runs below the beat's 6.9 for that window.
Last mentioned: Mar 22, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, ai-research. Of the tracked stories, 1 of 1 also mention AI/ML, the most common co-covered peer. Their average consequence score of 6 runs below the beat's 6.9 for that window. Each story carries 3 original sources on average, compared with 2.6 for the broader beat in this window. We currently track 1 AI story that mention Rare Lab, all published on March 22, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 31 AI stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Rare Lab. Shared-story counts are live from our verified record — not editorial picks.
Rare Lab is leveraging advanced machine learning to identify treatments for thousands of neglected rare diseases, bypassing traditional pharma's profit-driven constraints. By combining high-throughput screening with predictive AI models, the lab is accelerating the repurposing of existing drugs for patient populations that have long been ignored.
Rare Lab is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
